Poster: Tumour-infiltrating immune cell markers
Need some direction in choosing immune cell markers? Whether you are working with human cells or a mouse model, CST has you covered!
List view / Grid view
Need some direction in choosing immune cell markers? Whether you are working with human cells or a mouse model, CST has you covered!
Join Malvern Panalytical for a 15-minute webinar to learn about ex vivo inflammasome slice assays for neuroinflammation discovery.
Simultaneous multicolour imaging for successful experiments.
Read about the current state of the industry, challenges associated with potency assays and measuring product potency throughout the manufacturing process.
Understand how quality control assays are being implemented in monitoring the development of CAR-T cells using high-throughput technologies in this article.
Cytokine multiplex assays allow researchers to measure multiple cytokines, chemokines and growth factors from one small sample.
Discover key target cells for immunotherapy, how cells and processes can be assessed in vitro and approaches for selecting the most appropriate assay.
Measure protein, DNA and RNA in FFPE tissue samples using rigorously IHC validated CST antibodies on the NanoString® nCounter® platform.
Dr. Stokes, Associate Director Proteomics, discusses how proteomic studies can increase effectiveness, speed of target and biomarker identification.
This article highlights five of the latest findings revealed using CRISPR that could be used in the development or design of new therapies.
US scientists, using CRISPR technology, removed specific genes in humans to allow the immune system to be more activated against cancer.
Looking for solutions to resolve your unique challenges? We offer several customized products and services to move your discovery forward.
Trinity researchers have discovered the secret to viral resistance, by screening women exposed to HCV.
A UNIGE team reveals that a drug used against herpes can fight a bacterium that is resistant to most antibiotics by weakening its defence mechanisms.
Spanish researchers have discovered that vitamin C may hold the key to improving the efficacy of dendritic cell-derived anticancer therapies.